{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T18:11:19Z","timestamp":1789150279693,"version":"build-2803163510"},"reference-count":39,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2021QH344"],"award-info":[{"award-number":["ZR2021QH344"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2021QH260"],"award-info":[{"award-number":["ZR2021QH260"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:p>Liposarcoma (LPS) is a common soft tissue sarcoma; however, its molecular pathogenesis and immune cell infiltration remain poorly understood. This study investigated potential driver genes and pathways in LPS and characterized immune cell infiltration patterns to identify potential markers for targeted therapy. Differentially expressed genes (DEGs) in LPS were analyzed by GO and KEGG pathway enrichment analysis. A protein-protein interaction network was constructed using the STRING database and visualized with Cytoscape. mRNA expression of genes with high |logFC| values was verified by RT-qPCR. Immune cell subsets were quantified using CIBERSORT. GO and KEGG analysis revealed significant functional clusters and pathways, and most verified genes were consistent with the bioinformatics analysis. Survival analysis showed that high expression of TYMS, KIF20A, BUB1B, LMNB1, RRM2, ZWINT, and RACGAP1 was significantly associated with poor overall survival and poor disease-free survival (DFS). High levels of TMSB15A, TPX2, PKM2, and PTTG1 were significantly associated with poor DFS alone. CIBERSORT analysis identified a significantly higher fraction of resting mast cells (MCs) in LPS tissues compared to normal fatty tissues (P\u2009&lt;\u20090.05). TOP2A, IL-6, PCNA, CDK1, JUN, MYC, CCNB1, EGFR, ACACB, and BIRC5 were identified as potential diagnostic biomarkers of LPS, providing strong evidence for hub gene studies. Immune cell infiltration analysis further suggested that resting MCs may play a potential role in LPS development, although further experimental validation is warranted. Collectively, these findings clarify the molecular basis of LPS and provide a foundation for future research into its treatment.<\/jats:p>","DOI":"10.1371\/journal.pone.0358180","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T17:51:27Z","timestamp":1789149087000},"page":"e0358180","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Identification of functional genes and immune cell infiltration analysis in liposarcoma"],"prefix":"10.1371","volume":"21","author":[{"given":"Chunxiao","family":"Liu","sequence":"first","affiliation":[{"name":"Qilu Hospital of Shandong University","place":["Jinan, Shandong, China"],"department":["Department of Cardiovascular Surgery"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhua","family":"Wang","sequence":"additional","affiliation":[{"name":"Shandong Provincial Hospital Affiliated to Shandong First Medical University","place":["Jinan, Shandong, China"],"department":["Department of Critical Care Unit"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuxia","family":"Liu","sequence":"additional","affiliation":[{"name":"Shandong Provincial Hospital Affiliated to Shandong First Medical University","place":["Jinan, Shandong, China"],"department":["Department of Critical Care Unit"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0422-8227","authenticated-orcid":true,"given":"Sha","family":"Zhang","sequence":"additional","affiliation":[{"name":"Shandong Provincial Hospital Affiliated to Shandong First Medical University","place":["Jinan, Shandong, China"],"department":["Department of Critical Care Unit"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,9,11]]},"reference":[{"issue":"30","key":"pone.0358180.ref001","doi-asserted-by":"crossref","first-page":"3449","DOI":"10.2217\/fon-2021-1549","article-title":"Immunotherapy for liposarcoma: emerging opportunities and challenges","volume":"18","author":"Z Song","year":"2022","journal-title":"Future Oncol"},{"issue":"2","key":"pone.0358180.ref002","doi-asserted-by":"crossref","first-page":"70","DOI":"10.32074\/1591-951X-213","article-title":"The 2020 WHO classification of soft tissue tumours: news and perspectives","volume":"113","author":"M Sbaraglia","year":"2021","journal-title":"Pathologica"},{"key":"pone.0358180.ref003","doi-asserted-by":"crossref","first-page":"102013","DOI":"10.1016\/j.ctrv.2020.102013","article-title":"A review of retroperitoneal liposarcoma genomics","volume":"86","author":"R Tyler","year":"2020","journal-title":"Cancer Treat Rev"},{"issue":"9","key":"pone.0358180.ref004","doi-asserted-by":"crossref","first-page":"621","DOI":"10.2217\/fon-2022-1291","article-title":"Brightline-1: phase II\/III trial of the MDM2-p53 antagonist BI 907828 versus doxorubicin in patients with advanced DDLPS","volume":"19","author":"P Sch\u00f6ffski","year":"2023","journal-title":"Future Oncol"},{"issue":"2","key":"pone.0358180.ref005","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/PAS.0000000000001564","article-title":"DDIT3 immunohistochemistry is a useful tool for the diagnosis of myxoid liposarcoma","volume":"45","author":"JV Scapa","year":"2021","journal-title":"Am J Surg Pathol"},{"issue":"11","key":"pone.0358180.ref006","first-page":"1598","article-title":"Systemic therapy in advanced pleomorphic liposarcoma: a comprehensive review","volume":"24","author":"T Assi","year":"2023","journal-title":"Curr Treat Options Oncol"},{"issue":"22","key":"pone.0358180.ref007","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15225469","article-title":"Retroperitoneal soft tissue sarcoma: emerging therapeutic strategies","volume":"15","author":"E de Bree","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"2","key":"pone.0358180.ref008","doi-asserted-by":"crossref","first-page":"565","DOI":"10.3892\/or.2020.7635","article-title":"Identification of TYMS as a promoting factor of retroperitoneal liposarcoma progression: Bioinformatics analysis and biological evidence","volume":"44","author":"S Zhang","year":"2020","journal-title":"Oncol Rep"},{"issue":"18","key":"pone.0358180.ref009","article-title":"RRM2 regulates sensitivity to sunitinib and PD-1 blockade in renal cancer by stabilizing ANXA1 and activating the AKT pathway","volume":"8","author":"W Xiong","year":"2021","journal-title":"Adv Sci (Weinh)"},{"key":"pone.0358180.ref010","doi-asserted-by":"crossref","first-page":"739139","DOI":"10.3389\/fonc.2021.739139","article-title":"Anti-tumor effect of apatinib and relevant mechanisms in liposarcoma","volume":"11","author":"L Cui","year":"2021","journal-title":"Front Oncol"},{"issue":"3","key":"pone.0358180.ref011","doi-asserted-by":"crossref","first-page":"9420120","DOI":"10.26599\/FMH.2025.9420120","article-title":"Food and medicine homology in cancer treatment: traditional thoughts collide with scientific evidence","volume":"2","author":"M-Y Li","year":"2025","journal-title":"Food Med Homol"},{"issue":"10","key":"pone.0358180.ref012","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1158\/1535-7163.MCT-12-0920","article-title":"PI3K stimulates DNA synthesis and cell-cycle progression via its p55PIK regulatory subunit interaction with PCNA","volume":"12","author":"G Wang","year":"2013","journal-title":"Mol Cancer Ther"},{"issue":"7","key":"pone.0358180.ref013","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1002\/(SICI)1097-0142(19990401)85:7<1569::AID-CNCR19>3.0.CO;2-M","article-title":"The prognostic significance of proliferation-associated nucleolar protein p120 expression in prostate adenocarcinoma","volume":"85","author":"BVS Kallakury","year":"1999","journal-title":"Cancer"},{"issue":"3","key":"pone.0358180.ref014","doi-asserted-by":"crossref","first-page":"9420063","DOI":"10.26599\/FMH.2025.9420063","article-title":"Ferulic acid inhibiting colon cancer cells at different Duke\u2019s stages","volume":"2","author":"Z-P Liu","year":"2025","journal-title":"Food Med Homol"},{"issue":"3","key":"pone.0358180.ref015","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.01960-21","article-title":"Feedback loop regulation between Pim kinases and tax keeps human t-cell leukemia virus type 1 viral replication in check","volume":"96","author":"M Bellon","year":"2022","journal-title":"J Virol"},{"issue":"4","key":"pone.0358180.ref016","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1038\/sj.leu.2404585","article-title":"HTLV-I infection of WE17\/10 CD4+ cell line leads to progressive alteration of Ca2+ influx that eventually results in loss of CD7 expression and activation of an antiapoptotic pathway involving AKT and BAD which paves the way for malignant transformation","volume":"21","author":"H Akl","year":"2007","journal-title":"Leukemia"},{"issue":"1","key":"pone.0358180.ref017","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s12943-023-01827-6","article-title":"PI3K\/AKT\/mTOR signaling transduction pathway and targeted therapies in cancer","volume":"22","author":"A Glaviano","year":"2023","journal-title":"Mol Cancer"},{"issue":"3","key":"pone.0358180.ref018","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.3390\/ijms24032652","article-title":"The role of PI3K\/AKT\/mTOR signaling in hepatocellular carcinoma metabolism","volume":"24","author":"L-Y Tian","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"16","key":"pone.0358180.ref019","article-title":"PLEKHS1 drives PI3Ks and remodels pathway homeostasis in PTEN-null prostate","volume":"83","author":"TAM Chessa","year":"2023","journal-title":"Mol Cell"},{"issue":"8","key":"pone.0358180.ref020","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.3390\/cancers11081169","article-title":"The PTEN tumor suppressor gene in soft tissue sarcoma","volume":"11","author":"S Stefano","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"17","key":"pone.0358180.ref021","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.2174\/1871520622666220419135547","article-title":"Cryptolepine targets TOP2A and inhibits tumor cell proliferation in breast cancer cells - an in vitro and in silico study","volume":"22","author":"U Mehraj","year":"2022","journal-title":"Anticancer Agents Med Chem"},{"issue":"2","key":"pone.0358180.ref022","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/IGC.0000000000000607","article-title":"Evaluation of TOP2A as a predictive marker for endometrial cancer with taxane-containing adjuvant chemotherapy","volume":"26","author":"F Ito","year":"2016","journal-title":"Int J Gynecol Cancer"},{"issue":"10","key":"pone.0358180.ref023","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12102731","article-title":"Molecular pathogenesis of pancreatic ductal adenocarcinoma: impact of miR-30c-5p and miR-30c-2-3p regulation on oncogenic genes","volume":"12","author":"T Tanaka","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"22","key":"pone.0358180.ref024","doi-asserted-by":"crossref","first-page":"7072","DOI":"10.1158\/1078-0432.CCR-17-0413","article-title":"TOP2A and EZH2 provide early detection of an aggressive prostate cancer subgroup","volume":"23","author":"DP Labb\u00e9","year":"2017","journal-title":"Clin Cancer Res"},{"issue":"6","key":"pone.0358180.ref025","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1158\/1078-0432.CCR-21-1291","article-title":"Co-targeting of MDM2 and CDK4\/6 with siremadlin and ribociclib for the treatment of patients with well-differentiated or dedifferentiated liposarcoma: results from a proof-of-concept, phase ib study","volume":"28","author":"AR Abdul Razak","year":"2022","journal-title":"Clin Cancer Res"},{"issue":"2","key":"pone.0358180.ref026","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1158\/1078-0432.CCR-23-2469","article-title":"SAR-096: phase II clinical trial of ribociclib in combination with everolimus in advanced dedifferentiated liposarcoma (DDL) and leiomyosarcoma (LMS)","volume":"30","author":"S Movva","year":"2024","journal-title":"Clin Cancer Res"},{"issue":"1","key":"pone.0358180.ref027","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1186\/s13046-024-03228-z","article-title":"Mechanism of efficacy of trabectedin against myxoid liposarcoma entails detachment of the FUS-DDIT3 transcription factor from its DNA binding sites","volume":"43","author":"I Craparotta","year":"2024","journal-title":"J Exp Clin Cancer Res"},{"key":"pone.0358180.ref028","doi-asserted-by":"crossref","first-page":"117204","DOI":"10.1016\/j.biopha.2024.117204","article-title":"Molecular characteristics and systemic treatment options of liposarcoma: a systematic review","volume":"178","author":"X-P Zhou","year":"2024","journal-title":"Biomed Pharmacother"},{"key":"pone.0358180.ref029","doi-asserted-by":"crossref","first-page":"648917","DOI":"10.3389\/fimmu.2021.648917","article-title":"Deciphering the prognostic implications of the components and signatures in the immune microenvironment of pancreatic ductal adenocarcinoma","volume":"12","author":"R Tang","year":"2021","journal-title":"Front Immunol"},{"issue":"23","key":"pone.0358180.ref030","doi-asserted-by":"crossref","first-page":"10743","DOI":"10.7150\/thno.46719","article-title":"Mast cells as a unique hematopoietic lineage and cell system: from Paul Ehrlich\u2019s visions to precision medicine concepts","volume":"10","author":"P Valent","year":"2020","journal-title":"Theranostics"},{"issue":"21","key":"pone.0358180.ref031","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1111\/1759-7714.14654","article-title":"Controversial role of mast cells in NSCLC tumor progression and angiogenesis","volume":"13","author":"V Longo","year":"2022","journal-title":"Thorac Cancer"},{"issue":"1","key":"pone.0358180.ref032","first-page":"19","article-title":"Mast cells in tumor growth: angiogenesis, tissue remodelling and immune-modulation","volume":"1796","author":"S Maltby","year":"2009","journal-title":"Biochim Biophys Acta"},{"key":"pone.0358180.ref033","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S1937-6448(09)75004-X","article-title":"The controversial role of mast cells in tumor growth","volume":"275","author":"D Ribatti","year":"2009","journal-title":"Int Rev Cell Mol Biol"},{"issue":"1","key":"pone.0358180.ref034","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s10555-011-9286-z","article-title":"The significant role of mast cells in cancer","volume":"30","author":"K Khazaie","year":"2011","journal-title":"Cancer Metastasis Rev"},{"key":"pone.0358180.ref035","first-page":"120","article-title":"Mast cell: an emerging partner in immune interaction","volume":"3","author":"G Gri","year":"2012","journal-title":"Front Immunol"},{"issue":"4","key":"pone.0358180.ref036","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1182\/blood-2008-03-147033","article-title":"SCF-mediated mast cell infiltration and activation exacerbate the inflammation and immunosuppression in tumor microenvironment","volume":"112","author":"B Huang","year":"2008","journal-title":"Blood"},{"issue":"11","key":"pone.0358180.ref037","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1101\/gad.13.11.1382","article-title":"Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis","volume":"13","author":"LM Coussens","year":"1999","journal-title":"Genes Dev"},{"issue":"3","key":"pone.0358180.ref038","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s12016-019-08753-w","article-title":"Role of mast cells in shaping the tumor microenvironment","volume":"58","author":"DEA Komi","year":"2020","journal-title":"Clin Rev Allergy Immunol"},{"issue":"11","key":"pone.0358180.ref039","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.3724\/abbs.2022121","article-title":"ACACB is a novel metabolism-related biomarker in the prediction of response to cetuximab therapy inmetastatic colorectal cancer","volume":"54","author":"H-J Hong","year":"2022","journal-title":"Acta Biochim Biophys Sin (Shanghai)"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0358180","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T17:51:33Z","timestamp":1789149093000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0358180"}},"subtitle":[],"editor":[{"given":"Kangkang","family":"Ji","sequence":"first","affiliation":[{"name":"Huazhong Agriculture University","place":["CHINA"]}],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,9,11]]},"references-count":39,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9,11]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0358180","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,11]]}}}